Latest News

Title
Programme
Webcasts
12 Mar 2015 FDA Approves First Therapy for High-Risk Neuroblastoma Cancer in Special Situations - Anticancer agents & Biologic therapy
10 Mar 2015 FDA Approves First Biosimilar Product in the USA Palliative and supportive care
09 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Pegfilgrastim (Ristempa) Palliative and supportive care
06 Mar 2015 ESMO South-East Asia Summit: Meeting Resources
06 Mar 2015 FDA Expands Approved Use of Nivolumab to Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
05 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
04 Mar 2015 Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas Translational research - Gastrointestinal cancers
03 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Bevacizumab Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 Mar 2015 Adjuvant VEGF Inhibitors, Sorafenib or Sunitinib, do not Improve Outcomes in Resected Locally-Advanced Renal Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
27 Feb 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Ceritinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Feb 2015 FDA Approves Panobinostat for Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
23 Feb 2015 FDA Permits Marketing of First Direct-to-Consumer Genetic Carrier Test for Bloom Syndrome Epidemiology/Etiology/Cancer Prevention
20 Feb 2015 New HPV Vaccine Offers Greater Protection Against Cervical Cancer Than Current Vaccine Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies